Lsrfortessa cell analyzer flow cytometer
The BD LSRFortessa cell analyzer is a flow cytometer that enables the analysis and sorting of cells. It provides high-performance data acquisition and analysis capabilities for a wide range of applications.
Lab products found in correlation
23 protocols using lsrfortessa cell analyzer flow cytometer
Flow Cytometry Analysis of Cell Surface Markers
FACS Analysis of Cultured Cells
Cytokine Profiling of Immune Cell Responses
Flow Cytometry-based Orthogonal Drug Assay
titrated with various concentrations of the appropriate orthogonal
drugs. 1.5 μL of different concentrations of 100× concentrated
drug solution (TMP in Dimethyl sulfoxide (DMSO) and/or Shld-1 in absolute
Ethanol) was added to the wells to achieve the final concentration.
For cultures without any drug, corresponding volumes of solvents (DMSO
and/or Ethanol) were added. The plates were incubated for 72 h before
harvesting for measuring the fluorescence by flow cytometry: fluorescence
measurements were performed on a BD LSRFortessa cell analyzer flow
cytometer. The eGFP fluorescence was measured using a 488 nm excitation
laser and a 515–545 nm emission filter, while mCherry fluorescence
used 561 nm excitation and 600–620 nm emission. A minimum of
10 000 cells was measured from each sample. From these single-cell
fluorescence intensities, we further computed the mean fluorescence
intensity per cell representing the population average for both mCherry
and eGFP separately using the FlowJo software (Treestar, Inc., San
Carlos, CA). The mean eGFP fluorescence values were normalized to
mCherry fluorescence intensities after subtracting for autofluorescence
derived from mock-transfected cells. The resulting ratiometric scores
were further converted to %, based on the ratiometric score of the
control eGFP, without DDs or drug, but with the respective solvents
of the drugs.
Immunophenotypic Characterization of PL-MSCs
At passages 4–5, detach the PL-MSCs with TrypLE and calculate the cell number as per Step 19.
Wash the harvested cells 1–2 times with ice-cold PBS by centrifuging at 500 × g for 2 min.
Discard the supernatant and suspend the cells in PBS at 2 × 106 cells/ml.
Aliquot 1 × 105 cells or 50 μL of cell suspension in each of the pre-labeled 5 mL FACS tubes.
Add the respective antibodies to the tubes and incubate in ice for 1 h. Mouse isotype antibodies serve as controls.
Acquire at least 10,000 events on BD LSRFortessa Cell Analyzer flow cytometer and analyze the results using BD FACSDiva software.
Representative data from a PL-MSC culture at passage 4 is presented in Immunophenotypic characterization of isolated PL-MSCs The antibodies used were (A) human CD73, (B) human CD90 (C) human CD105 (D) human CD166 (E) human CD34 (F) human HLA-DR and their respective isotype controls. Open histogram indicates background signal, while, shaded histogram represents positive reactivity with the indicated antibodies. Table shows percentage of cells expressing the respective surface markers (n = 3) in mean ± SEM.
SARS-CoV-2-Specific B Cell Detection
Quantifying Cellular Reactive Oxygen Levels
Cytofluorometric Analysis of Ploidy
A BD LSR Fortessa Cell Analyzer flow cytometer (BD Biosciences, San Jose, CA, USA) was used. Chimaeric embryos were analysed for the presence of fluorescent introduced cells and their ploidy.
Th1/Th2 Cytokine Profiling in Raw 264.7 Cells
Comprehensive Flow Cytometry Analysis of MSCs
Non-fixed ICF cells were sorted at Passage 3 using the SH800Z Cell Sorter (Sony Biotechnology, USA) for the HLA-A,B,C+/CD34−/PDGFRα+ subpopulation to exclude germ cells and endothelial cells from the sorted population. Non-viable cells were excluded by the use of 7-AAD (BD Biosciences, USA). For both analysis and sorting, we determined background fluorescence levels by using matched conjugated IgG isotype controls. The details of the antibodies that were used can be found in
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!